NRX Pharmaceuticals Inc NRXP:NASDAQ

Last Price$0.71NASDAQ Closing Price as of 4:00PM ET 8/19/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change-0.03(3.65%)
Bid (Size)$0.70 (10)
Ask (Size)$0.74 (4)
Day Low / High$0.70 - 0.75
Volume462.5 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 08/19/2022

 

NRX Pharmaceuticals Inc ( NASDAQ )

Price: $0.71
Change: -0.03 (3.65%)
Volume: 462.5 K
4:00PM ET 8/19/2022
 
 

Carlotz Inc ( NASDAQ )

Price: $0.48
Change: -0.03 (6.73%)
Volume: 1.1 M
4:00PM ET 8/19/2022
 
 

Allied Esports Entertainment Inc ( NASDAQ )

Price: $1.53
Change: 0.00 (0.00%)
Volume: 35.9 K
4:00PM ET 8/19/2022
 
 

Lion Group Holding Ltd ( NASDAQ )

Price: $1.31
Change: -0.01 (0.76%)
Volume: 136.7 K
4:00PM ET 8/19/2022
 
 

180 Life Sciences Corp ( NASDAQ )

Price: $0.95
Change: -0.03 (3.06%)
Volume: 127.1 K
3:59PM ET 8/19/2022
 

Read more news Recent News

Insider Sell: NRX Pharmaceuticals
5:46PM ET 8/02/2022 MT Newswires

Daniel C. Javitt, 10% Owner, on July 29, 2022, sold 784,063 shares in NRX Pharmaceuticals (NRXP) for $791,433. Following the Form 4 filing with the SEC,...

NRX Pharmaceuticals Names Stephen Willard CEO
7:41AM ET 7/13/2022 MT Newswires

NRX Pharmaceuticals (NRXP) said Wednesday it has named Stephen Willard chief executive officer, and a member of the company's board of directors. Willard...

NRx Pharmaceuticals Says FDA Declines Emergency Use Authorization for COVID-19-Driven Respiratory Failure Therapy
7:59AM ET 7/01/2022 MT Newswires

NRx Pharmaceuticals (NRXP) said Friday the US Food and Drug Administration declined to approve its aviptadil therapy for emergency use authorization. The...

--HC Wainwright Starts NRX Pharmaceuticals at Buy With $2 Price Target
6:22AM ET 6/30/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionNRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE. View company web site for more details
Address1201 Orange Street
Wilmington, Delaware 19801
Phone+1.484.254.6134
Number of EmployeesN/A
Recent SEC Filing08/15/202210-Q
Chief Executive Officer & DirectorStephen H. Willard
Chief Commercial Officer & Head-OperationsRobert Besthof
Chief Financial Officer & TreasurerSeth L. van Voorhees
Chief Strategy OfficerDennis K. McBride

Company Highlights

Price Open$0.73
Previous Close$0.74
52 Week Range$0.49 - 16.99
Market Capitalization$48.2 M
Shares Outstanding67.6 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement11/15/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$7.95
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-736.15%

Analyst Ratings as of 06/29/2022

Buy
1
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset